2015
DOI: 10.24966/orp-2052/100016
|View full text |Cite
|
Sign up to set email alerts
|

Megaprosthesis Revision Caused by Aseptic Loosening and Nonunion of the Structural Allograft in Patients Younger Than 40 Years

Abstract: Background: The use of structural allografts is aimed to restore the resected bone segment in order to maintain enough bone stock for future revisions. The aim of this study was to describe the mechanical failures of Allograft Megaprosthesis Composite (AMC) revised to Modular Megaprosthesis (MMP) due to nonunion of the structural allograft in patients younger than 40 years. Material and methods:A retrospective revision in a referral hospital for the treatment of musculoskeletal tumors was performed between Jan… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 19 publications
0
1
0
Order By: Relevance
“…Total femur replacements were first introduced for Paget’s disease in 1956 by Buchman [ 7 ]. Improvement in implant design and modularity has allowed for their utilization in an array of oncologic and nononcologic conditions [ [8] , [9] , [10] , [11] ]. Despite this evolution, recent literature shows a 33% failure rate of total femur replacements in the setting of revision surgery in a relatively young patient population with nononcologic conditions [ 12 ].…”
Section: Discussionmentioning
confidence: 99%
“…Total femur replacements were first introduced for Paget’s disease in 1956 by Buchman [ 7 ]. Improvement in implant design and modularity has allowed for their utilization in an array of oncologic and nononcologic conditions [ [8] , [9] , [10] , [11] ]. Despite this evolution, recent literature shows a 33% failure rate of total femur replacements in the setting of revision surgery in a relatively young patient population with nononcologic conditions [ 12 ].…”
Section: Discussionmentioning
confidence: 99%